LORI RUMAN: Open Payments
NPI 1326097270 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$252 in 13 payments from 10 companies in 2025. Trend: 2023 $318 · 2024 $483 · 2025 $252
Food & beverage: $252
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 2 | $49 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $33 |
| Astellas Pharma US Inc | 1 | $29 |
| Axsome Therapeutics, Inc. | 2 | $28 |
| Novo Nordisk Inc | 1 | $25 |
| Lundbeck LLC | 1 | $22 |
| Exeltis, USA Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| Innovation Technologies Inc | 1 | $14 |
Products named: NEXPLANON, Veozah, Symbravo, Wegovy, REXULTI, SLYND, LO LOESTRIN FE, NURTEC ODT.
Industry payments across ID — which companies pay providers there.
